|
NXF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.322300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.967860E-02 |
| Normal-vs-Stage2 |
6.334000E-02 |
| Normal-vs-Stage3 |
3.794400E-01 |
| Normal-vs-Stage4 |
1.607820E-01 |
| Stage1-vs-Stage2 |
5.678000E-01 |
| Stage1-vs-Stage3 |
2.075200E-01 |
| Stage1-vs-Stage4 |
6.299400E-01 |
| Stage2-vs-Stage3 |
1.885250E-01 |
| Stage2-vs-Stage4 |
4.154400E-01 |
| Stage3-vs-Stage4 |
5.719400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.593600E-02 |
| Normal-vs-AfricanAmerican |
9.992600E-04 |
| Normal-vs-Asian |
3.478700E-03 |
| Caucasian-vs-AfricanAmerican |
2.361100E-03 |
| Caucasian-vs-Asian |
6.202400E-02 |
| AfricanAmerican-vs-Asian |
6.000600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.797200E-01 |
| Normal-vs-Female |
2.404900E-04 |
| Male-vs-Female |
5.594100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.270200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.479300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.027200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.752800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.272000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.691400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.506200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.278200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.698600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.808200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.23819999978225E-07 |
| Normal-vs-Grade 2 |
2.275500E-03 |
| Normal-vs-Grade 3 |
4.113400E-01 |
| Normal-vs-Grade 4 |
6.479400E-01 |
| Grade 1-vs-Grade 2 |
4.48950000000448E-05 |
| Grade 1-vs-Grade 3 |
5.70500000018903E-07 |
| Grade 1-vs-Grade 4 |
3.92370000046327E-07 |
| Grade 2-vs-Grade 3 |
9.215900E-03 |
| Grade 2-vs-Grade 4 |
4.275500E-02 |
| Grade 3-vs-Grade 4 |
8.410600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.296200E-03 |
| Normal-vs-ccB subtype |
9.279600E-01 |
| ccA subtype-vs-ccB subtype |
4.987400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.354400E-02 |
| Normal-vs-N1 |
8.941600E-01 |
| N0-vs-N1 |
2.985600E-01 |
|
|
